SCHEMBL162530

SCHEMBL162530

CC(N)CC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627121 1.00
SCHEMBL14174686 1.00
Water SCHEMBL30786947 0.97
Hydrochloric Acid SCHEMBL28870455 0.97
Hydrochloric Acid SCHEMBL28870478 0.97
Hydrochloric Acid SCHEMBL28870457 0.97
SCHEMBL21482326 0.80 FDPS (0.33)
SCHEMBL5403032 0.79 ALDH1A1 (0.41)
Trifluoroacetic Acid SCHEMBL15541905 0.78 FDPS (0.38)
Cadaverine Tartrate SCHEMBL28870467 0.78 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114920651-A Synthesis method of (S) -4, 4-dimethyl-2-pentylamine hydrochloride 吉尔多肽生物制药(大连市)有限公司 2022-08-19 CN claimed
US-20090170847-A1 Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same YUYU PHARMA, INC. (KR) 2009-07-02 US claimed
EP-1984370-A1 IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Crystalgenomics, Inc. (KR) 2008-10-29 EP claimed
WO-2007083978-A1 IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME CRYSTALGENOMICS, INC. (KR) 2007-07-26 WO claimed
CN-112533902-B Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers 埃科莱布美国股份有限公司 2025-03-14 CN disclosed
US-12023383-B2 Lipid compositions ARBUTUS BIOPHARMA CORPORATION (CA) 2024-07-02 US disclosed
US-20240066129-A1 LIPID COMPOSITIONS ARBUTUS BIOPHARMA CORPORATION (US) 2024-02-29 US disclosed
EP-3820846-B1 COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER ECOLAB USA INC (US) 2024-01-03 EP disclosed
US-20230357166-A1 PIPERAZINE-BASED CATIONIC LIPIDS TRANSLATE BIO, INC. 2023-11-09 US disclosed
US-20230312648-A1 PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES YUYU PHARMA, INC. (KR) 2023-10-05 US disclosed
US-20230312648-A1 PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES YUYU PHARMA, INC. (KR) 2023-10-05 US disclosed
CN-116783204-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-09-19 CN disclosed
US-20040044056-A1 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-03-04 US disclosed
EP-1342717-A1 BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-09-10 EP disclosed
US-4491671-A Process for the preparation of N-substituted imido-dicarboxylic acid diaryl esters BAYER AKTIENGESELLSCHAFT (DE) 1985-01-01 US disclosed
EP-0048376-B1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED DIARYL IMIDODICARBOXYLATES BAYER AG (DE) 1984-02-15 EP disclosed
EP-0048377-B1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED DIARYL IMIDODICARBOXYLATES BAYER AG (DE) 1983-10-19 EP disclosed
US-4348331-A FROM THE HYDROCHLORIDE OF A PRIMARY AMINE AND AN ARYL ESTER HALIDE BAYER AKTIENGESELLSCHAFT (DE) 1982-09-07 US disclosed
EP-0048376-A1 Process for the preparation of N-substituted diaryl imidodicarboxylates BAYER AG (DE) 1982-03-31 EP disclosed
US-4129580-A Resolution of certain asymmetric primary amines using lasalocid HOFFMANN-LA ROCHE INC. (US) 1978-12-12 US disclosed